BACKGROUND: Women with hypertensive disorders in pregnancy, in particular early-onset preeclampsia, are at increased risk of developing cardiovascular disease later in life. These women have a more than 2-fold increased risk of dying from cardiovascular diseases. Most studies have focused on identification of risk factors shortly after pregnancy. Less is known on the prevalence of risk factors or actual signs of cardiovascular disease 5-20 years later. The presence of hypertension or metabolic syndrome can be seen as an opportunity for preventive interventions to reduce the development of severe cardiovascular diseases like myocardial infarction and stroke.OBJECTIVE: To assess cardiovascular risk factors and established cardiovascular disea...
Objective To analyse the predicted 10- and 30-year risk scores for cardiovascular disease (CVD) in p...
Contains fulltext : 154708.pdf (publisher's version ) (Closed access)OBJECTIVE: To...
Preeclampsia is one of the leading causes of maternal and fetal mortality and morbidity. Furthermore...
BACKGROUND: Women with hypertensive disorders in pregnancy, in particular early-onset preeclampsia, ...
BACKGROUND: Women with hypertensive disorders in pregnancy, in particular early-onset preeclampsia, ...
BACKGROUND: Women with hypertensive disorders in pregnancy, in particular early-onset preeclampsia, ...
BACKGROUND: Women with hypertensive disorders in pregnancy, in particular early-onset preeclampsia, ...
Objective: to assess the prevalence of established cardiovascular disease risk factors and to estima...
Item does not contain fulltextIntroduction: Preeclampsia is a complication of pregnancy and a known ...
Introduction: Preeclampsia is a complication of pregnancy and a known risk factor for cardiovascular...
Background: Cardiovascular disease is the cause of death in 32% of women in the Netherlands. Predict...
Objective To analyse the predicted 10- and 30-year risk scores for cardiovascular disease (CVD) in p...
OBJECTIVE: To analyse the predicted 10- and 30-year risk scores for cardiovascular disease (CVD) in ...
ABSTRACT: BACKGROUND: Cardiovascular disease is the cause of death in 32% of women in the Netherland...
Objective To analyse the predicted 10- and 30-year risk scores for cardiovascular disease (CVD) in p...
Objective To analyse the predicted 10- and 30-year risk scores for cardiovascular disease (CVD) in p...
Contains fulltext : 154708.pdf (publisher's version ) (Closed access)OBJECTIVE: To...
Preeclampsia is one of the leading causes of maternal and fetal mortality and morbidity. Furthermore...
BACKGROUND: Women with hypertensive disorders in pregnancy, in particular early-onset preeclampsia, ...
BACKGROUND: Women with hypertensive disorders in pregnancy, in particular early-onset preeclampsia, ...
BACKGROUND: Women with hypertensive disorders in pregnancy, in particular early-onset preeclampsia, ...
BACKGROUND: Women with hypertensive disorders in pregnancy, in particular early-onset preeclampsia, ...
Objective: to assess the prevalence of established cardiovascular disease risk factors and to estima...
Item does not contain fulltextIntroduction: Preeclampsia is a complication of pregnancy and a known ...
Introduction: Preeclampsia is a complication of pregnancy and a known risk factor for cardiovascular...
Background: Cardiovascular disease is the cause of death in 32% of women in the Netherlands. Predict...
Objective To analyse the predicted 10- and 30-year risk scores for cardiovascular disease (CVD) in p...
OBJECTIVE: To analyse the predicted 10- and 30-year risk scores for cardiovascular disease (CVD) in ...
ABSTRACT: BACKGROUND: Cardiovascular disease is the cause of death in 32% of women in the Netherland...
Objective To analyse the predicted 10- and 30-year risk scores for cardiovascular disease (CVD) in p...
Objective To analyse the predicted 10- and 30-year risk scores for cardiovascular disease (CVD) in p...
Contains fulltext : 154708.pdf (publisher's version ) (Closed access)OBJECTIVE: To...
Preeclampsia is one of the leading causes of maternal and fetal mortality and morbidity. Furthermore...